These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 24013873)

  • 1. Transgenic Rat Models of Huntington's Disease.
    Carreira JC; Jahanshahi A; Zeef D; Kocabicak E; Vlamings R; von Hörsten S; Temel Y
    Curr Top Behav Neurosci; 2015; 22():135-47. PubMed ID: 24013873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal sensitivity to excitotoxicity in a transgenic Huntington's disease rat.
    Winkler C; Gil JM; Araújo IM; Riess O; Skripuletz T; von Hörsten S; Petersén A
    Brain Res Bull; 2006 Apr; 69(3):306-10. PubMed ID: 16564426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons learned from the transgenic Huntington's disease rats.
    Vlamings R; Zeef DH; Janssen ML; Oosterloo M; Schaper F; Jahanshahi A; Temel Y
    Neural Plast; 2012; 2012():682712. PubMed ID: 22852099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental models of Huntington's disease].
    García-Ramos R; del Val-Fernández J; Catalán-Alonso MJ; Barcia-Albacar JA; Matías-Guiu J
    Rev Neurol; 2007 Oct 1-15; 45(7):437-41. PubMed ID: 17918112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexistence of Gait Disturbances and Chorea in Experimental Huntington's Disease.
    Casaca-Carreira J; Temel Y; van Zelst M; Jahanshahi A
    Behav Neurol; 2015; 2015():970204. PubMed ID: 26063966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microstructural changes observed with DKI in a transgenic Huntington rat model: evidence for abnormal neurodevelopment.
    Blockx I; De Groof G; Verhoye M; Van Audekerke J; Raber K; Poot D; Sijbers J; Osmand AP; Von Hörsten S; Van der Linden A
    Neuroimage; 2012 Jan; 59(2):957-67. PubMed ID: 21906685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered emotional and motivational processing in the transgenic rat model for Huntington's disease.
    Faure A; Höhn S; Von Hörsten S; Delatour B; Raber K; Le Blanc P; Desvignes N; Doyère V; El Massioui N
    Neurobiol Learn Mem; 2011 Jan; 95(1):92-101. PubMed ID: 21111837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of neurophysiological biomarkers for Huntington's disease: evaluating a phosphodiesterase 9A inhibitor.
    Nagy D; Tingley FD; Stoiljkovic M; Hajós M
    Exp Neurol; 2015 Jan; 263():122-31. PubMed ID: 25315303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased numbers of motor activity peaks during light cycle are associated with reductions in adrenergic alpha(2)-receptor levels in a transgenic Huntington's disease rat model.
    Bode FJ; Stephan M; Wiehager S; Nguyen HP; Björkqvist M; von Hörsten S; Bauer A; Petersén A
    Behav Brain Res; 2009 Dec; 205(1):175-82. PubMed ID: 19573560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice.
    Stack EC; Kubilus JK; Smith K; Cormier K; Del Signore SJ; Guelin E; Ryu H; Hersch SM; Ferrante RJ
    J Comp Neurol; 2005 Oct; 490(4):354-70. PubMed ID: 16127709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington's disease.
    Nguyen HP; Kobbe P; Rahne H; Wörpel T; Jäger B; Stephan M; Pabst R; Holzmann C; Riess O; Korr H; Kántor O; Petrasch-Parwez E; Wetzel R; Osmand A; von Hörsten S
    Hum Mol Genet; 2006 Nov; 15(21):3177-94. PubMed ID: 16984963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic and electrophysiological changes in the basal ganglia of transgenic Huntington's disease rats.
    Vlamings R; Benazzouz A; Chetrit J; Janssen ML; Kozan R; Visser-Vandewalle V; Steinbusch HW; von Hörsten S; Temel Y
    Neurobiol Dis; 2012 Dec; 48(3):488-94. PubMed ID: 22813864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Rodent Models of Huntington Disease.
    Stricker-Shaver J; Novati A; Yu-Taeger L; Nguyen HP
    Adv Exp Med Biol; 2018; 1049():29-57. PubMed ID: 29427097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citicoline is not protective in experimental models of Huntington's disease.
    Mievis S; Levivier M; Vassart G; Brotchi J; Ledent C; Blum D
    Neurobiol Aging; 2007 Dec; 28(12):1944-6. PubMed ID: 17064815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine A2A receptor blockade before striatal excitotoxic lesions prevents long term behavioural disturbances in the quinolinic rat model of Huntington's disease.
    Scattoni ML; Valanzano A; Pezzola A; March ZD; Fusco FR; Popoli P; Calamandrei G
    Behav Brain Res; 2007 Jan; 176(2):216-21. PubMed ID: 17123640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An experimental model for Huntington's chorea?
    Zeef DH; Jahanshahi A; Vlamings R; Casaca-Carreira J; Santegoeds RG; Janssen ML; Oosterloo M; Temel Y
    Behav Brain Res; 2014 Apr; 262():31-4. PubMed ID: 24412685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA microarray analysis of striatal gene expression in symptomatic transgenic Huntington's mice (R6/2) reveals neuroinflammation and insulin associations.
    Crocker SF; Costain WJ; Robertson HA
    Brain Res; 2006 May; 1088(1):176-86. PubMed ID: 16626669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplants of adult mesenchymal and neural stem cells provide neuroprotection and behavioral sparing in a transgenic rat model of Huntington's disease.
    Rossignol J; Fink K; Davis K; Clerc S; Crane A; Matchynski J; Lowrance S; Bombard M; Dekorver N; Lescaudron L; Dunbar GL
    Stem Cells; 2014 Feb; 32(2):500-9. PubMed ID: 23939879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive deterioration of reaction time performance and choreiform symptoms in a new Huntington's disease transgenic ratmodel.
    Cao C; Temel Y; Blokland A; Ozen H; Steinbusch HW; Vlamings R; Nguyen HP; von Hörsten S; Schmitz C; Visser-Vandewalle V
    Behav Brain Res; 2006 Jun; 170(2):257-61. PubMed ID: 16569446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neurodegenerative process in a neurotoxic rat model and in patients with Huntington's disease: histopathological parallels and differences.
    Gunčová I; Látr I; Mazurová Y
    Acta Histochem; 2011 Dec; 113(8):783-92. PubMed ID: 21193226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.